Table of Contents
Table 5-21: Fayette
Table 5-23: Fountain
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2002 | 1998 - 2002 | 2002 | 1998 - 2002 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 204 | 656.4 | 949 | 627.5 | 77 | 256.0 | 383 | 269.5 |
| Esophagus | * | # | 15 | 10.2** | * | # | 17 | 12.1** |
| Stomach | * | # | 12 | 8.8** | * | # | 8 | 5.4** |
| Colon excluding Rectum | 11 | 36.3** | 72 | 48.5 | * | # | 30 | 22.1 |
| Rectum and Rectosigmoid Junction | 7 | 22.4** | 34 | 22.2 | * | # | 2 | # |
| Liver | * | # | 11 | 6.8** | * | # | 10 | 6.0** |
| Pancreas | * | # | 15 | 9.3** | * | # | 16 | 9.9** |
| Lung and Bronchus | 38 | 120.0 | 187 | 122.0 | 25 | 77.1 | 149 | 99.5 |
| Melanoma of the Skin | * | # | 28 | 17.9 | * | # | 4 | # |
| Prostate | 59 | 192.7 | 274 | 188.3 | 6 | 25.5** | 37 | 31.9 |
| Urinary Bladder | 18 | 57.9** | 74 | 49.7 | * | # | 14 | 11.3** |
| Kidney and Renal Pelvis | 7 | 21.1** | 28 | 17.5 | * | # | 5 | 3.8** |
| Brain and Other Nervous System | * | # | 15 | 9.0** | * | # | 6 | 3.3** |
| Non-Hodgkin Lymphoma | 5 | 16.5** | 31 | 19.5 | 5 | 16.1** | 14 | 10.7** |
| Myeloma | * | # | 7 | 4.9** | * | # | 5 | 3.8** |
| Leukemia | 7 | 20.8** | 22 | 14.7 | 5 | 17.6** | 15 | 10.6** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2002 | 1998 - 2002 | 2002 | 1998 - 2002 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 182 | 445.3 | 885 | 441.0 | 89 | 211.7 | 400 | 194.7 |
| Colon excluding Rectum | 15 | 35.0** | 82 | 39.3 | 10 | 23.2** | 40 | 19.3 |
| Rectum and Rectosigmoid Junction | * | # | 25 | 12.4 | * | # | 4 | # |
| Liver | * | # | 5 | 2.5** | * | # | 4 | # |
| Pancreas | * | # | 24 | 11.4 | 6 | 14.3** | 21 | 10.0 |
| Lung and Bronchus | 38 | 92.0 | 146 | 72.0 | 35 | 82.1 | 119 | 58.2 |
| Melanoma of the Skin | 6 | 16.2** | 28 | 14.8 | * | # | 3 | # |
| Breast | 59 | 146.8 | 274 | 137.9 | 9 | 21.4** | 58 | 28.4 |
| Cervix Uteri | * | # | 12 | 6.1** | * | # | 6 | 3.0** |
| Corpus Uteri | 7 | 17.6** | 43 | 21.8 | * | # | 7 | 3.5** |
| Ovary | 6 | 15.1** | 36 | 18.3 | 6 | 14.0** | 26 | 12.9 |
| Urinary Bladder | 5 | 11.4** | 27 | 13.0 | * | # | 9 | 4.5** |
| Kidney and Renal Pelvis | 6 | 14.5** | 27 | 13.2 | * | # | 8 | 3.7** |
| Brain and Other Nervous System | * | # | 7 | 3.6** | * | # | 3 | # |
| Non-Hodgkin Lymphoma | 5 | 11.1** | 26 | 12.6 | * | # | 19 | 9.1** |
| Myeloma | * | # | 6 | 3.0** | * | # | 5 | 2.5** |
| Leukemia | * | # | 21 | 10.7 | * | # | 14 | 6.5** |
Rates are per 100,000; Age-adjusted, 2000 US Std Million Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2005
Table of Contents
Table 5-21: Fayette
Table 5-23: Fountain
